SAN JOSE, Calif.—A chemist who worked astatine Theranos Inc. testified Friday astir the technological failures that plagued the defunct blood-testing startup, arsenic the high-stakes fraud lawsuit wrapped up a 2nd week of witnesser grounds successful a national courthouse.
Surekha Gangakhedkar, a elder idiosyncratic astatine the institution for 8 years who discontinue successful 2013 due to the fact that of her concerns astir the blood-testing technology, described a workplace wherever employees were kept successful silos and Elizabeth Holmes, institution laminitis and suspect successful the case, pressured employees to validate laboratory tests earlier they were acceptable to beryllium utilized connected patients.
/etf_analysis_proshares_ultrapro_nasdaq_biotech__ss-5bfc3af846e0fb0051c1e7d5.jpg)
English (US) ·